Rigel Pharmaceuticals Inc.

03/11/2021 | Press release | Distributed by Public on 03/11/2021 06:36

Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients